Karim Benjelloun is a Senior Vice President at Lumanity, where he helps biopharma companies make more confident business-critical decisions that shape the value of their clinical assets and of the organizations that bring them to patients. He brings more than 25 years’ experience in life sciences strategy, commercialization and organizational effectiveness, with a focus in oncology and hematology, from global pharma to biotech companies.
Karim has shaped pre-commercialization and launch strategies for more than 20 clinical assets, spanning indication prioritization, opportunity assessments, go-to-market strategy, launch readiness, competitive positioning and response, post-launch growth, and cross-functional alignment. Among other work, he supported the development of the first commercialization blueprint for a CAR-T cell therapy platform at a top 10 pharmaceutical company.
Before joining Lumanity, Karim co-founded and led ScienceFirst, a Scientific Engagement agency, and then founded JOLT, a launch and commercial excellence focused life sciences firm. More recently he advised biopharma clients on organizational transformation and team innovation while at a-connect. As a business leader, Karim focuses on building strong, collaborative teams and empowering them to exceed client expectations.
Karim holds an MBA in Strategic Management from the Wharton School of the University of Pennsylvania and a BSBA in Marketing from both Northeastern University and IFAM (Institut Franco-Americain de Management).